Figure 1 | Scientific Reports

Figure 1

From: Matrix metalloproteinase inhibitor, doxycycline and progression of calcific aortic valve disease in hyperlipidemic mice

Figure 1

Doxycycline administration in apoE−/− mice.

(A) Body weight in control and doxycycline-treated apoE−/− mice on high fat diet, measured during the 3 month-period of drug administration. n = 10 in each group. (B) Blood doxycycline concentrations measured by high performance liquid chromatography in doxycycline-treated and control animals. n = 2 in each group.

Back to article page